Severity of hippocampal atrophy correlates with the prolongation of MRI T2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease

Neurology

Volumn 46, Issue 6, 1996, Pages 1724-1730

  Pitkanen A ^a   Laakso, M ^b   Kalviainen R ^b   Partanen, K ^b   Vainio, P ^b   Lehtovirta, M ^b   Riekkinen Sr , P ^a,b   Soininen, H ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN INJURY; BRAIN SIZE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLIOSIS; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NERVE CELL NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TEMPORAL LOBE EPILEPSY;

EID: 0029888694     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.6.1724     Document Type: Article

References (54)

1. Margerison JH, Corsellis JAN. Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy with particular reference to the temporal lobes. Brain 1966;89:499-530.
2. Gloor P. Mesial temporal sclerosis: historical background and an overview from a modern perspective. In: Lüders H, ed. Epilepsy surgery. New York: Raven Press, 1991;689-703.
3. Meldrum BS, Corsellis JAN. Epilepsy. In: Hume Adams J, Corsellis JAN, Duchen LW, eds. Greenfield's neuropathology, 4th ed. New York: Wiley-Medical Publication, John Wiley & Sons, 1984:921-950.
4. Sutula T, Cascino G, Cavazos J, Parada I, Ramirez L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 1989;26:321-330.
5. Cendes F, Anderman F, Dubeau F, et al. Early childhood prolonged febrile convulsions, atrophy and sclerosis of mesial structures, and temporal lobe epilepsy. An MRI volumetric study. Neurology 1993;43:1083-1087.
6. Cook MJ. Mesial temporal sclerosis and volumetric investigations. Acta Neurol Scand 1994;152(Suppl):109-114.
7. Saukkonen A, Kälviäinen R, Partanen K, Vainio P, Riekkinen P, Pitkänen A. Do seizures cause neuronal damage? An MRI study in newly diagnosed and chronic epilepsy. Neuroreport 1994;6:219-223.
8. Lencz T, McCarthy G, Bronen RA, et al. Quantitative magnetic resonance imaging in temporal lobe epilepsy: relationship to neuropathology and neuropsychological function. Ann Neurol 1992;31:629-637.
9. Jackson GD, Connelly A, Duncan JS, Grünewald RA, Gadian DG. Detection of hippocampal pathology in intractable partial epilepsy. Increased sensitivity with quantitative magnetic resonance T2 relaxometry. Neurology 1993;43:1793-1799.
10. Kramer RE, Luders H, Lesser RP, et al. Transient focal abnormalities of neuroimaging studies during focal status epilepticus. Epilepsia 1987;28:528-532.
11. Callahan DJ, Noetzel MJ. Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities. Neurology 1992;42:2198-2201.
12. Horowitz S, Merchut M, Fine M, Azar-Kia B. Complex partial seizure-induced transient MRI enhancements. J Comput Assist Tomogr 1992;16:814-816.
13. Henry T, Drury I, Brunberg J, Pennell P, McKeever P, Beydoun A. Focal cerebral magnetic resonance changes associated with partial status epilepticus. Epilepsia 1994;35:35-41.
14. Nohria V, Lee N, Tien RD, et al. Magnetic resonance imaging evidence of hippocampal sclerosis in progression: a case report. Epilepsia 1994;35:1332-1336.
15. Yaffe K, Ferriero D, Barkovich J, Rowley H. Reversible MRI abnormalities following seizures. Neurology 1995;45:104-108.
16. Meiners LC, van Gils A, Jansen GH, et al. Temporal lobe epilepsy: the various MR appearances of histologically proven mesial temporal sclerosis. AJNR 1994;15:1547-1555.
17. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991;41:51-54.
18. Jack JR Jr., Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188.
19. Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 1993;50:949-954.
20. Lehericy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer's disease. AJNR 1994;15:927-937.
21. Laakso MP, Soininen H, Partanen K, et al. Volumes of the hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm [P-D Sect] 1995;9:73-86.
22. Deweer B, Lehericy S, Pillon B, et al. Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. J Neurol Neurosurg Psychiatry 1995;58: 590-597.
23. Kirsch SJ, Jacobs RW, Butcher LL, Beatty J. Prolongation of magnetic resonance T2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease. Neurosci Lett 1992;134:187-190.
24. Laakso MP, Partanen K, Soininen H, et al. MR T2 relaxometry in Alzheimer's disease and age-associated memory impairment. Neurobiol Aging (in press).
25. Hyman BT, Damasio AR, Van Hoesen GW, Barnes CL. Alzheimer's disease: cell specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170.
26. Drayer BP. Imaging of the aging brain. Part II. Pathologic conditions. Radiology 1988;166:797-806.
27. Scheltens P, Barkhof F, Leys D, Wolters E, Ravid R, Kamphorst W. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 1995;45:883-888.
28. Soininen H, Partanen K, Pitkänen A, et al. Volumes of the amygdala and the hippocampus in age-associated memory impairment: correlation to visual and verbal memory. Neurology 1994;44:1660-1668.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
30. Mourizen-Dam A. Hippocampal neuron loss in epilepsy and after experimental seizures. Acta Neurol Scand 1982;66:601-642.
31. Cavazos JE, Das I, Sutula TP. Neuronal loss induced in limbic pathways by kindling: evidence for induction of hippocampal sclerosis by repeated brief seizures. J Neurosci 1994;14:3106-3121.
32. Meencke HJ, Veith G. Hippocampal sclerosis in epilepsy. In: Lüders H, ed. Epilepsy surgery. New York: Raven Press, 1991: 705-715.
33. Free SL, Bergin PS, Fish DR, Cook MJ, Shorvon SD, Stevens JM. Hippocampal volume correction: identification of bilateral volume loss [abstract]. Epilepsia 1994;35(Suppl 8):87.
34. Connelly A, Incisa della Rocchetta A, Jackson GD, et al. Seizure and cognitive outcome after surgery: the role of contralateral temporal lobe damage as revealed by quantitative proton MRS and T2 relaxometry [abstract]. Epilepsia 1994; 35(Suppl 8):17.
35. Jackson GD, Cross HJ, Connelly A, Neville BGR, Gadian DG. Hippocampal T2 relaxometry in intractable childhood epilepsy reveals substantial subgroup with severe bilateral hippocampal sclerosis [abstract]. Epilepsia 1994;35(Suppl 8):20.
36. Cross JH, Jackson GD, Connelly A, Neville BGR, Gadian DG. Lateralization of temporal lobe abnormalities in children with temporal lobe epilepsy: the role of quantitative proton magnetic resonance spectroscopy [abstract]. Epilepsia 1994; 35(Suppl 8):17.
37. Mourizen-Dam A. Epilepsy and neuron loss in the hippocampus. Epilepsia 1980;21:617-629.
38. Babb TL, Pretorius JK. Pathologic substrates of epilepsy. In: Wylie E, ed. The treatment of epilepsy: principles and practice. Philadelphia: Lea & Febiger, 1993:55-70.
39. Darwin RH, Drayer BP, Riederer SJ, Wang HZ, MacFall JR. T2 estimates in healthy and diseased brain tissue: a comparison using various MR pulse sequences. Radiology 1986;160: 375-381.
40. Van Paesschen W, Revesz T, Duncan JS, et al. Quantitative neuropathology and quantitative MRI of hippocampal sclerosis [abstract]. Epilepsia 1994;35(Suppl 8):19.
41. Härtig W, Hausen D, Brauer K, Arendt T, Bigl V, Brückner G. Digoxigenin-tagged anti-GFAP and multiple labeling of human glia, vessels and β-amyloid. Neuroreport 1994;5:573-576.
42. Vijayan VK, Zhou S-S, Russell MJ, Geddes J, Ellis W, Cotman CW. Perineuronal satellitosis in the human hippocampal formation. Hippocampus 1993;3:239-250.
43. Beaurain J, Clemenceau S, Hauw J-J, Duyckaerts C, Baulac M. Morphological features of glial cell population associated with human hippocampal sclerosis [abstract]. Epilepsia 1994; 35(Suppl 8):62.
44. Kaneko Y, Kitamoto T, Tateishi J, Yamaguchi K. Ferritin immunohistochemistry as a marker for microglia. Acta Neuropathol 1989;79:129-136.
45. Leveugle B, Spik G, Perl D, Bouras C, Fillit HM, Hof PR. The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res 1994;650:20-31.
46. Barzokis G, Sultzer D, Mintz J, et al. In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI. Biol Psychiatry 1994;35:480-487.
47. Thomas LO, Boyko OB, Anthony DC, Burger PC. MR detection of brain iron. Am J Neuroradiol 1993;14:1043-1048.
48. Drayer B, Burger P, Darwin R, Riederer S, Herfkens R, Johnson GA. Magnetic resonance imaging of brain iron. AJNR 1986;7:373-380.
49. Gomori JM, Grossman RI. The relation between regional brain iron and T2 shortening. AJNR 1993;14:1049-1050.
50. Schenker C, Meier D, Wichmann W, Boesiger P, Valavanis A. Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen. Neuroradiology 1993;35:119-124.
51. Huesgen CT, Burger PC, Crain BJ, Johnson GA. In vitro MR microscopy of the hippocampus in Alzheimer's disease. Neurology 1993;43:145-152.
52. Mackenzie IRA, Miller LA. Senile plaques in temporal lobe epilepsy. Acta Neuropathol 1994;87:504-510.
53. Grünewald RA, Jackson GD, Connelly A, Duncan JS. MR detection of hippocampal disease in epilepsy: factors influencing T2 relaxation time. AJNR 1994;15:1149-1156.
54. Karlik S. Common pharmaceuticals alter tissue proton NMR relaxation properties. Magn Res Med 1986;3:181-193.